TrialBMC pulmonary medicine2025

Comparison of ICS dose reduction vs. montelukast discontinuation for step-down therapy in well-controlled asthma: a pilot randomized controlled trial.

Besharat Rahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.